News

Media Release

Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

May 11, 2021
Media Release

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

March 24, 2021
Media Release

Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests

December 10, 2020
Media Release

Lucence Launches DeepMARK™ for Profiling of SARS-CoV-2 Subgenomic RNA

October 7, 2020
Media Release

Lucence Launches SAFER™ Technology Suite for Accurate COVID-19 Detection Using Naso-Oropharyngeal Saliva

August 18, 2020
Media Release

Lucence and Akribis Collaborate on COVID-19 Saliva Processing Automated Platform to Enable Mass Testing

July 2, 2020
Media Release

Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus

June 16, 2020
Highlights

Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

May 26, 2020
Highlights

Lucence announces the launch of SARS-CoV-2 RNA RT-PCR clinical testing service to support Singapore’s anti-COVID-19 efforts.

May 25, 2020
Media Release

Genomics company Lucence develops viral sample collection medical device for COVID-19 diagnosis and surveillance

March 20, 2020
Media Release

Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

January 14, 2020
Highlights

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

November 20, 2019
View More
Events

Changing Care Worldwide at ASCO 2020

June 1, 2020

Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry

 GenomeWeb January 27, 2020

Singapore Investors Plow into Healthcare Startups

 Nikkei Asian Review December 24, 2019

Lucence Raises $20M to Advance Liquid Biopsy

 BioSpectrum November 28, 2019

Firm Behind Non-invasive Cancer Tests Receives $27m Funding

 The Straits Times November 25, 2019

Malaysia’s IHH Leads $20m Injection for Cancer-test Startup Lucence

 Nikkei Asian Review November 22, 2019

Singapore: IHH Leads Series A Round for Lucence

 LaingBuisson November 21, 2019

Lucence Attracts $20M in Series A to Scale Up Operations

 BioWorld November 21, 2019

Cancer Screening Startup Lucence Raises US$20m in Funding Led by IHH

 The Business Times November 20, 2019

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

 Xconomy November 20, 2019

Malaysia’s IHH Healthcare Leads $20m Funding in SG-based Cancer Screening Firm

 Deal Street Asia November 20, 2019

Lucence Raises $20 Million Series A for its Non-invasive Cancer Screening Technology

 TechCrunch November 20, 2019
Need Help?